Outpace Bio logo

Outpace Bio

Seattle, WA

Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.

outpacebio.com

Company Details

Founded

2020

Employees

Between 50 - 100 employees

Raised

$55,000,000

Headquarters Location

Seattle, WA

Public

No

Acquired

No

CEO

Marc LajoieMarc Lajoie

Founders

Scott Boyken
Scott Boyken
Marc Lajoie
Marc Lajoie

Company Collections

These are collections Outpace Bio is a part of. Click on the collection name to view similar companies.

Outpace Bio's Tech Stack